V-ATPase a3 isoform mutations identified in osteopetrosis patients abolish its expression and disrupt osteoclast function

Area of Science:

• Biochemistry
• Cell Biology
• Genetics

Background:

• The a3 isoform of vacuolar-type proton-pumping ATPase (V-ATPase) is crucial for osteoclast-mediated bone resorption.
• Over 90 mutations in the human a3 gene are linked to infantile malignant osteopetrosis, but their functional impact on osteoclasts remains unclear.

Purpose of the Study:

• To investigate the functional consequences of specific a3 gene mutations on osteoclast activity and V-ATPase function.
• To determine if identified mutations in the a3 cytosolic domain lead to osteoclast dysfunction.

Main Methods:

• Established an in vitro assay to generate osteoclasts from a3-knockout mouse spleen macrophages.
• Examined the expression, V-ATPase assembly, and calcium phosphate resorption activity of osteoclasts expressing mutant a3 proteins (two short deletions, two missense mutations).
• Assessed the interaction of mutant a3 proteins with Rab7.

Main Results:

• Osteoclasts expressing a3 with short deletions showed impaired expression and calcium phosphate resorption.
• Osteoclasts expressing a3 with missense mutations exhibited normal expression levels, V-ATPase assembly, and calcium phosphate resorption activity.
• Missense mutants successfully interacted with Rab7, indicating preserved lysosomal trafficking pathways.

Conclusions:

• Short deletions in the a3 subunit disrupt V-ATPase assembly and impair osteoclast bone resorption.
• Missense mutations in the a3 cytosolic domain, as studied, do not appear to cause osteoclast dysfunction or significantly impair bone resorption.
• Further investigation may be needed to understand the role of these missense mutations in the context of additional genetic factors or specific bone resorption processes.